Effect of a potent hypolipemic agent on glycogen metabolism.
D000818:Animals; D001393:Azoles / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism; D006003:Glycogen / Q000096:biosynthesis / Q000378:metabolism*; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D009132:Muscles / Q000378:metabolism*; D011725:Pyridines / Q000494:pharmacology
D001393:Azoles; D000960:Hypolipidemic Agents; D007328:Insulin; D011725:Pyridines; D006003:Glycogen; D005947:Glucose